Not Found
On Demand

Biomarkers for Early Detection of Alzheimer's Disease

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
State Associations:
IOA - Indiana
IOA 2020 Spring Update - Package 2 Geriatrics
Sophia Wang, MD, MD
42 Minutes
Never expires.


Title: Biomarkers for Early Detection of Alzheimer’s Disease

Presenter: Sophia Wang, M.D.


By the end of this session, participants will be able to:

1)  Understand the "classical" clinical approach to diagnose mild cognitive impairment and early stage dementias using clinical assessment and neuropsychological testing.

2)  Understand the A-T-N framework as the novel biological definition of Alzheimer's disease

3)  Understand the appropriate use criteria for amyloid imaging and the findings of the IDEAS clinical trial.

4)  Understand other novel biomarkers used for early detection for mild cognitive impairment and Alzheimer's disease.


The Indiana Osteopathic Association (IOA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.  The IOA designates this program for a maximum of .75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

It is the policy of the IOA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA.  Complaints on Evaluation Forms also are taken into consideration when planning future CME programs and may lead to changes in the format or content.





Sophia Wang, MD, MD's Profile

Sophia Wang, MD, MD Related seminars and products: 4

Dr. Wang is an assistant professor of clinical psychiatry at Indiana University School of Medicine. She completed her M.D. degree and her general psychiatry residency at the Mount Sinai School of Medicine in New York, NY.  She then pursued a neurosciences fellowship focusing on neurodegenerative disorders at the James J. Peters VAMC affiliated with the Mount Sinai School of Medicine, and a geriatric psychiatry clinical fellowship at the University of California in San Francisco, CA. Dr. Wang currently is funded on a NIA K23 Career Development Award to examine how delirium and vascular risk factors may increase the risk of long-term cognitive impairment in intensive care unit survivors. Her awards include the 2018 Beeson Travel Award and the 2018 Hartford-Jeste Award for Future Leaders in Geriatric Psychiatry from the American Psychiatric Association. She also currently serves as the Leader of the Outreach, Recruitment, and Engagement Core at the NIA funded Indiana Alzheimer Disease Center.

Alternate Options

Update in Clinical Dermatology
Original Program Date: 04/23/2020
Lung Nodules
Original Program Date: 04/23/2020
Autism Update
Original Program Date: 04/24/2020
Type 2 Diabetes Mellitus Treatment Updates
Original Program Date: 04/24/2020
Type 2 Diabetes Mellitus Treatment Updates
Original Program Date: 04/24/2020
COPD Update
Original Program Date: 04/24/2020
Atopic Dermatitis
Original Program Date: 04/24/2020
Direct Primary Care 101
Original Program Date: 04/25/2020
BPH Update
Original Program Date: 04/25/2020

Please wait ...

Back to Top